جستجوی استاد راهنمای دانشگاهی

Leah Cramp is an Associate Lecturer in the School of Health Sciences within the College of Health, Medicine and Wellbeing at the University of Newcastle, Australia. With nearly a decade of clinical experience as a Radiation Therapist, she transitioned to academia in 2018, bringing practical expertise to her teaching role while serving as Outreach Program Manager for the University's Global Centre for Research and Training in Radiation Oncology, engaging over 2,000 high school students annually. She holds a Bachelor of Medical Radiation Science from the University of Newcastle (2008) and enhanced her pedagogical skills through the University's Certificate in Teaching and Fundamentals in University Teaching Certificate (2019). Her research centers on improving global radiation therapy utilization through innovative educational interventions, particularly targeting General Practitioners' knowledge of Radiation Oncology. She investigates systemic barriers across patient, departmental, and health professional domains, driven by alignment with United Nations Sustainable Development Goals to reduce global disparities in cancer care access. Cramp's publication trajectory (2016-2025) reveals a strategic evolution from technical radiotherapy protocols to comprehensive health services research. Her recent scoping reviews dissect multi-level barriers to radiation therapy access, while earlier work established clinical methodologies like bladder scanning protocols for prostate cancer treatment, demonstrating consistent focus on optimizing real-world radiation oncology delivery. Her scientific recognition includes: 2021 College of Health Medicine and Wellbeing Celebrating Staff Success Award for Industry Engagement 2013 MNC LHD Health Innovation Award in Cancer Services 2013 AIR ASMMIRT Best Poster Presentation Winner Cramp provides extensive student mentorship through clinical supervision and academic guidance, having trained radiation therapy students during her clinical tenure and currently supporting university students through coursework development and personalized academic support. Her Higher Degree by Research explores global radiation therapy access solutions, reflecting her dual commitment to education and systemic healthcare improvement. As Outreach Program Manager for the Global Centre for Research and Training in Radiation Oncology, she spearheads industry sustainability initiatives through high school engagement programs and collaborates on international cancer care projects, including the Hunter-led global radiation oncology center established in 2022.

• Radiation Therapy
• Radiation Oncology
• Medical Education
• +۳ مورد دیگر

Tee Lim is a Clinical Associate Professor at the UWA Medical School , Department of Surgery , The University of Western Australia. His research bridges clinical practice with innovations in artificial intelligence and radiation therapy , focusing on oncology and cardiology applications. Academic Affiliation: Clinical Associate Professor, UWA Medical School, Surgery Department University: The University of Western Australia Email: tee.lim@uwa.edu.au Location: 35 Stirling Highway, 6009 Perth, Australia Lim's work integrates AI-driven biomarkers into prostate cancer treatment protocols and develops stereotactic radioablation for managing refractory ventricular tachycardia. His research aligns with the United Nations Sustainable Development Goals (SDGs) , particularly SDG 3 (Good Health and Well-being) and SDG 9 (Industry, Innovation and Infrastructure). Recent studies highlight multidisciplinary collaborations in Australia and global research networks, emphasizing clinical translation and technological implementation in medical practice. He contributes to peer-reviewed journals like BMC Cancer and Heart Rhythm , with a Scopus h-index of 1 and 1 citation.

• Oncology
• Cardiology
• Artificial Intelligence
• +۳ مورد دیگر

Dr. Monish Aron is Professor of Clinical Urology at the Keck School of Medicine, University of Southern California, where he also serves as Vice Chair of Clinical Operations and Director of the Center for Outpatient Cancer Ablation. He is a specialist in robotic and laparoscopic surgery for malignant and benign conditions of the prostate, kidney, bladder, adrenal gland, and ureter. Dr. Aron trained in urology at premier institutions in India, Australia, and the United States, completing his fellowship training in advanced robotics and laparoscopy at the Cleveland Clinic before joining USC in 2009. His research interests focus on minimally invasive surgical techniques in urologic oncology, particularly robotic prostate and kidney surgery, single incision laparoscopic surgery, and robotic surgery for bladder cancer. Dr. Aron has made significant contributions to the refinement of robotic radical cystectomy with intracorporeal urinary diversion, salvage robotic radical prostatectomy, and techniques to prevent complications in complex urologic surgeries. Analysis of Dr. Aron's recent publications (2022-2025) reveals a strong focus on improving outcomes in robotic cystectomy and prostatectomy, with particular attention to urinary diversion techniques, enhanced recovery protocols, and innovative approaches to prevent and manage surgical complications. His work spans both technical surgical innovations and broader healthcare system factors affecting patient outcomes. GB Ong Medal from the Royal College of Surgeons of Edinburgh Multiple awards for scientific presentations at the American Urological Association Congress Multiple awards for surgical videos at the American Urological Association Congress Dr. Aron has mentored numerous trainees in robotic and laparoscopic urologic surgery techniques and has received extensive research funding to support his work in minimally invasive urologic oncology. He serves as a reviewer for 8 leading urologic journals and holds editorial board appointments for 3 journals, demonstrating his leadership in the field. He directs the Center for Outpatient Cancer Ablation at USC and has been instrumental in developing protocols for enhanced recovery after surgery in urologic oncology patients. Dr. Aron is frequently invited to speak and demonstrate surgical techniques at national and international institutions, reflecting his reputation as a pioneer in robotic urologic surgery.

• Robotic Surgery
• Laparoscopic Surgery
• Urologic Oncology
• +۶ مورد دیگر

Professor Arul Earnest is a leading academic research biostatistician at Monash University's School of Public Health & Preventive Medicine, where he serves as Deputy Head of the Clinical Outcomes Data Reporting and Research Program (CORRP). He holds a Professor (Research) appointment in Biostatistics, Data Analytics/Modelling, and Health Economics. His expertise spans Bayesian spatio-temporal modelling, machine learning applications in healthcare, and clinical registries analysis. He coordinates the MPH5270 unit on Advanced Statistical Methods for Clinical Research and developed the 'Clinical Registries Data Analysis using Stata' course. His research collaborations include government bodies, patient advocacy groups, and international organizations, with a focus on improving healthcare data quality and patient outcomes. Professor Earnest has authored over 245 peer-reviewed publications, a textbook on biostatistical collaboration, and earned 19 scientific awards. He manages a statistical team supporting ~30 clinical registries and leads national projects on ovarian cancer management, real-time patient outcome measures, and chronic disease priority-setting strategies. His work contributes to UN Sustainable Development Goals addressing health and well-being (SDG 3), and he actively participates in grant review panels, ethics committees, and statistical conferences.

• Biostatistics
• Health Economics
• Clinical Registries
• +۴ مورد دیگر

Prof. Di Muzio Nadia Gisella is a Full Professor at Vita-Salute San Raffaele University, holding the role of Professore Ordinario in Medicine (MEDS-22/A). She also served as Associate Professor since 2019 and has held contract professorships at the University of Milan-Bicocca and University of Milan in Radiation Oncology and Medical Physics. She is Head of the Radiation Oncology Department at San Raffaele Scientific Institute since 2008. Her academic training includes a Medical Degree from University of Milan (1988) and specialization in oncological radiotherapy (1992), with advanced training at University of Wisconsin and New York University. She completed a managerial training at Bocconi University (2009). Her research focuses on radiation treatment optimization for prostate cancer, including brachytherapy and hypofractionated techniques, with a strong emphasis on integrating imaging modalities like PET/CT and radiomics. She explores radiation-immune system interactions and their implications for immunotherapy combinations. Over 200 peer-reviewed publications and leadership roles in international societies (SIURO, ESTRO) highlight her expertise. She coordinates the Italian Brachytherapy Group and participates in European research initiatives. Prof. Di Muzio leads the Tomotherapy Unit (2007-2008) and chairs the Italian Prostatic Brachytherapy group. She advises on Hadron Therapy in Pavia and Candiolo Cancer Institute. Her clinical work involves advanced head/neck cancer protocols and phase III trials in colorectal/breast cancers. She is a pioneer in precision radiotherapy using functional imaging and has developed predictive models for treatment outcomes.

• Radiation Oncology
• Prostate Cancer Treatment
• Brachytherapy
• +۵ مورد دیگر

Univ.-Prof. Dr. med. Michael Andreas Schäfers is a Full Professor of Nuclear Medicine and Director of the European Institute for Molecular Imaging (EIMI) and the Department of Nuclear Medicine at the University of Münster. He holds leadership roles, including Chairman of the German Universities Nuclear Medicine National Committee and membership in multiple medical societies. His expertise spans molecular imaging, translational research, and hybrid imaging techniques. Education includes a PhD from the University of Münster (1995) and habilitation (1999). Professional milestones include research at the MRC Cyclotron Unit (London, 1994–1995) and tenure-track professorship (1999–2007). His research focuses on multimodal molecular imaging, targeted imaging probes, cardiovascular inflammation, apoptosis, and hybrid imaging technologies. Key research interests include development of radiopharmaceuticals, PET/MRI integration, and imaging of inflammatory and oncological processes. Notable contributions include studies on FAP-directed radioligand therapy, S100A8/A9 alarmins, and glutamine's role in acute kidney injury. He has authored over 300 publications and holds patents on imaging agents. Scientific awards include recognition from Focus-Ärzteliste (2022), BurdaVerlag, and the Young Investigator Award (2004). He supervises the CiM-IMPRS Graduate Programme and contributes to clinical trials in oncology and radiopharmacology. His labs at EIMI and the Translational Imaging Group advance imaging technologies and preclinical/clinical collaborations.

• Molecular Imaging
• Nuclear Medicine
• Multimodal Imaging
• +۷ مورد دیگر

Professor Ruth Endacott is an Honorary Professor at the School of Nursing and Midwifery, University of Plymouth, and serves as Project Lead for the South West Clinical Schools and Director of the Plymouth University/Royal Devon and Exeter Hospital Clinical School. Her academic roles are complemented by extensive clinical and educational leadership in critical care nursing and patient safety. Her research focuses on acute care nursing, particularly in intensive care units (ICUs), patient safety protocols, and end-of-life care. She has supervised over 25 doctoral students exploring topics such as patient deterioration management, family involvement in ICU care, and nursing competencies. Her work emphasizes interdisciplinary collaboration and patient-centered approaches, with contributions to international guidelines like the European Society of Intensive Care Medicine's end-of-life care standards. Recent studies highlight her expertise in patient escalation pathways, psychological impacts on healthcare workers during crises, and innovations in self-management strategies for chronic conditions. She actively promotes patient and public involvement (PPIE) in research, ensuring community voices shape healthcare policies and practices. Prof. Endacott’s contributions extend to educational reforms, including clinical skills training and feedback mechanisms for nursing students. She has pioneered studies on nurse staffing models during pandemics and resilience-building strategies for frontline staff. Her work bridges academic research with clinical practice, aiming to improve outcomes for critically ill patients and enhance healthcare systems globally.

• Critical Care Nursing
• Patient Safety
• Healthcare Education
• +۴ مورد دیگر

Professor Johann de Bono is a world-leading clinician-scientist at The Institute of Cancer Research (ICR), an independent college of the University of London, and the Royal Marsden Hospital (RMH). He serves as Head of the Division of Clinical Studies and co-founded/leads the Royal Marsden Drug Development Unit and ICR/RMH Experimental Cancer Medicine Centre team. His research focuses on prostate cancer, with groundbreaking work in biomarker-driven clinical trials, DNA repair defects, and targeted therapies. Developed PARP inhibitors (talazoparib, niraparib, olaparib) for advanced prostate cancer Transformed international guidelines for germline testing in prostate cancer Established molecular stratification frameworks for prostate cancer treatment His clinical trials revolutionized prostate cancer care, with key contributions to abiraterone, cabazitaxel, enzalutamide, and lutetium PSMA therapies. Publications span top-tier journals including Nature, Science, Cell, NEJM, and The Lancet. 2020 - Elected Fellow of the Royal Society of Biology 2018 - AACR Joseph H. Burchenal Memorial Award 2016 - Regius Professor of Cancer Research 2012 - AACR Team Science Award 2011 - ESMO Award He founded and leads the RM Prostate Cancer Targeted Therapy Group team, with a research focus on genomic landscape mapping of advanced prostate cancer and circulating biomarker applications.

• Prostate cancer
• Clinical trials
• Targeted therapy
• +۵ مورد دیگر

Dr. Welmoed van Deen is an Assistant Professor at the Erasmus School of Health Policy & Management, Erasmus University Rotterdam, where she is affiliated with the Department of Health Services Management & Organisation (HSMO). Her work bridges research and practice in health services, focusing on value-based healthcare and learning health systems. Her research interests center on improving healthcare delivery through data-driven insights. She specializes in analyzing routinely collected health data—including electronic medical records, insurance claims, and patient-reported outcomes—to evaluate care quality and patient preferences. Her primary clinical focus is inflammatory bowel disease, but she also conducts research in Parkinson’s disease, prostate and thyroid cancer, irritable bowel syndrome, and emergency medicine. She applies advanced methods in health services research, healthcare analytics, and medical statistics to generate actionable evidence. The recent trend in her publications reflects a strong commitment to patient-centered care and implementation science. Her work spans topics such as remission communication in IBD, remote monitoring in Parkinson’s, outcome feedback for quality improvement, and real-world treatment patterns in oncology. These studies highlight her interdisciplinary approach, combining clinical insight with epidemiological and statistical rigor. Dr. van Deen has contributed to over 40 peer-reviewed scientific articles, many published in high-impact journals. While no specific awards or fellowships are listed, her research aligns with the UN Sustainable Development Goal 3 (Good Health and Well-being), particularly through efforts to enhance healthcare quality and equity. She collaborates extensively across disciplines and institutions, contributing to team-based research in complex health systems. Though no formal advising role or grant funding is mentioned, her active publication record suggests ongoing involvement in research projects and mentorship within her academic environment. Dr. van Deen is also associated with research networks in both the United States and the Netherlands, working with national and regional learning health systems to translate evidence into practice. Her ORCID profile (0000-0002-4836-9849) provides a full record of her scholarly output.

• Health Services Research
• Value-Based Healthcare
• Learning Health Systems
• +۱۲ مورد دیگر

Dr. Julie Burns is a Visiting Research Fellow at the School of Medicine, University of Leeds, where she serves as laboratory manager for the Molecular Biology of Urothelial Cancers research group led by Professor M. Knowles. She has been based at the Robert Ogden Building, St James's University Hospital since joining the university in 2009, combining laboratory management with active research in bladder cancer genetics. Education: BSc, University of Edinburgh PhD in Genetics, University of Edinburgh Her research focuses on modeling bladder cancer development through gene editing and overexpression in primary normal urothelial cells, using both 2D and 3D culture systems. Her work integrates molecular biology techniques to understand key genetic mechanisms in urothelial carcinogenesis. Earlier in her career, she investigated the role of HPV16 proteins and explored gene therapy approaches for prostate cancer by targeting bacterial nitroreductase expression to tumor cells. Dr. Burns has a strong international research background, having conducted postdoctoral work at the Hospital for Sick Children in Toronto, the Beatson Institute for Cancer Research in Glasgow, and the YCR Cancer Research Unit at the University of York. Her expertise spans cancer genetics, cellular senescence, and gene therapy. Professional Memberships: Biochemical Society American Association for Cancer Research (AACR) She is actively involved in laboratory leadership and welcomes inquiries from prospective PhD students interested in cancer research. No scientific awards or publications are listed in the provided profile, but her sustained research contributions across multiple institutions highlight her role in advancing molecular oncology.

• Cancer Genetics
• Bladder Cancer
• Molecular Biology
• +۷ مورد دیگر

Dr. Jessica Scholey is an Associate Professor in the Department of Radiation Oncology at the University of California, San Francisco School of Medicine. She serves as Physics Director of the MRI Simulation Program and Physics Lead of the Proton Ocular Program. Dr. Scholey joined UCSF faculty in 2017 and holds a PhD in Bioengineering from the Joint UC Berkeley-UCSF Program, an MSc in Medical Physics from the University of Pennsylvania, and a BA in Physics from UC Berkeley. Her research integrates medical imaging, proton therapy, and deep learning to advance radiation oncology. Primary interests include MRI applications for treatment planning, AI-driven image synthesis, and sustainable radiotherapy practices. She leads educational initiatives in MRI and proton therapy at UCSF and collaborates with the UCSF Center for Intelligent Imaging. Dr. Scholey's recent publications (2022-2025) demonstrate strong focus on AI-enhanced medical imaging for radiation therapy, including synthetic CT generation, motion management in abdominal/liver radiotherapy, and proton therapy optimization. Her work frequently involves validating novel imaging techniques through clinical studies and phantom models. She maintains active membership in professional societies including the American Association of Physicists in Medicine, International Society for Magnetic Resonance in Medicine, and Particle Therapy Co-Operative Group.

• Medical Physics
• Radiation Oncology
• MRI Applications
• +۳ مورد دیگر

Alessandro Gabrielli is a Full Professor at the Department of Physics and Astronomy "Augusto Righi" at the University of Bologna, where he also serves as Coordinator of the PhD Course in Physics. His primary scientific discipline is PHYS-01/A Experimental physics of fundamental interactions and applications. He is affiliated with both the National Institute for Nuclear Physics (INFN) and CERN in Geneva. His research focuses on experimental physics, particularly electronic technologies applied to particle accelerators. His current research activities center on the ATLAS experiments at CERN in Geneva and DUNE in the United States. More recently, he has expanded his research interests to include cybersecurity, artificial intelligence, and quantum computing, aligning with new international research initiatives in applied physics. Professor Gabrielli has been engaged in numerous national and international research projects, collaborating extensively with the National Institute for Nuclear Physics. He has coordinated multiple experimental research activities and authored over 1,000 publications in international peer-reviewed journals. His H-Index is 116 (SCOPUS, February 2025). His scientific recognition includes serving as Editor in Chief for MDPI Journals: Electronics since 2021, Guest Editor for special issues on Microelectronics in 2023, and Editor of Frontiers in Detector Science and Technology. He has also served as a reviewer for the Dutch Research Council (NWO) for a grant of €280,000. In terms of academic guidance, he has supervised 6 PhD theses in Physics, 1 PhD thesis in Data Science and Computation, and 14 Master's theses in Physics at the University of Bologna. His research has been supported by multiple grants, including a PRIN 2022 grant of 173k€ for "High performance microelectronics for low-noise cryogenic applications" and an AlmaIdea 2022 grant of 24,000€ for developing a Hardware Firewall. Professor Gabrielli is actively involved in international collaborations, having served as a "Visiting Scientist" at the Rutherford Appleton Laboratory in the UK (2009), "Visiting Professor" at the Center for Human Space Robotics at the Italian Institute of Technology (2012-2013), and "Project Associate" contractor at CERN (2008-2010). He currently coordinates the Bologna section of the INFN for the DUNE experiment and various ATLAS hardware activities.

• Experimental physics of fundamental interactions
• Electronic technologies for particle accelerators
• High-energy physics experiments
• +۷ مورد دیگر

Annie Hendry serves as a Research Officer at Bangor University's North Wales Medical School, focusing on primary care intervention studies with emphasis on end-of-life care, cancer detection, and care home health systems. Her research integrates mixed-methods approaches to evaluate complex healthcare interventions across community and clinical settings. Her doctoral training centered on Smoking, lung cancer, and symptom presentation pathways in primary care Patient and smoker experiences in cancer diagnosis Barriers to timely healthcare engagement Hendry's research portfolio demonstrates consistent thematic evolution toward process evaluation methodologies in complex healthcare interventions. Early work examined cancer diagnostic pathways (2015-2020), while recent publications (2022-2025) increasingly focus on care home innovation , end-of-life symptom management , and primary care system optimization . Her fingerprint reveals dominant expertise in process evaluation (94%), carer support systems (88%), and subcutaneous drug delivery (85%), with growing emphasis on neonatal care environments and prostate cancer diagnostics. Key recognition includes: 2024 St David Award Finalist (shared with CARiAD study team) Hendry's collaborative approach is evident in multi-institutional projects like the CARiAD feasibility RCT and ThinkCancer! intervention development. Her work consistently addresses implementation challenges in real-world healthcare settings, particularly focusing on workforce innovation (role substitution in care homes), patient-centered care models (home-based end-of-life care), and systemic barrier reduction (cancer detection pathways). Current projects examine neonatal unit environments and prostate cancer diagnostic journeys through multi-perspective methodologies. Her research operates within Bangor University's health sciences ecosystem, leveraging partnerships between the North Wales Medical School and care home networks across Wales. Recent projects demonstrate strong alignment with NHS priorities in domiciliary care, cancer diagnosis, and oral health for vulnerable populations.

• Primary Care
• End-of-Life Care
• Process Evaluation
• +۵ مورد دیگر

Dr. Da Zhang is a Professor in the Department of Pathology and Laboratory Medicine at the University of Kansas Medical Center. He serves as Program Director of the Hematopathology Fellowship, Director of Hematopathology, and Medical Director of the Bone Marrow Lab. His roles integrate clinical leadership, academic research, and fellowship training program management. Education: MD in Medicine from Shandong Medical University, MSC in Science from Chinese Center for Disease Control and Prevention Research Interests: Dr. Zhang's translational research focuses on hematopoietic neoplasms and genitourinary (GU) malignancies, with particular emphasis on Castleman's disease, lymphomas, and leukemia . His work explores molecular pathways (e.g., Wnt signaling) and biomarkers in hematological and solid tumors. Publication Trends: In 2022, Dr. Zhang published studies on diagnostic methodologies in leukemia, prognostic biomarkers in prostate cancer, and molecular genetic comparisons across hematological disorders. His work bridges clinical practice (flow cytometry applications) and mechanistic research (AR/Wnt signaling in cancer progression). Scientific Awards Fellow, College of American Pathologists (2007–Present) Fellow, United States and Canadian Academy of Pathology (2007–Present) Labs & Teams: As Medical Director of the Bone Marrow Lab and director of the Hematopathology program, Dr. Zhang leads clinical and research operations in hematological diagnostics and training initiatives.

• Hematopathology
• Hematopoietic Neoplasms
• Genitourinary Research
• +۳ مورد دیگر

John H. Sinard, MD, PhD is a Professor of Pathology and of Ophthalmology and Visual Science at Yale School of Medicine, where he serves as Medical Director of Pathology Informatics. As a board-certified anatomic pathologist with specialty interest in ophthalmic pathology, he practices across multiple subspecialty areas while leading innovative informatics initiatives. Dr. Sinard founded the Pathology Informatics Program at Yale and has been developing medical software for over 30 years. Dr. Sinard's educational background includes: Bachelor's degree from Harvard University (1982) MD and PhD from Johns Hopkins University (1990) Residency at Yale-New Haven Hospital (1993) Fellowship at Yale University School of Medicine (1995) Dr. Sinard's primary research interests focus on translational informatics - delivering modern data management tools to practicing physicians and researchers. His work centers on pathology informatics, practice management, quality assurance, and patient safety. He emphasizes that proper design of information systems is crucial for their usefulness in patient care rather than being obstacles. His academic interests include integrating information systems into daily pathology practice to direct workflow, manage resources, and guide medical decisions, with custom software development often providing the greatest gains in workflow optimization and patient safety. Analysis of Dr. Sinard's recent publications reveals a strong focus at the intersection of pathology and informatics, with growing emphasis on artificial intelligence applications in pathology. His work spans ocular pathology, particularly uveal melanoma and other eye diseases, while maintaining a consistent thread of pathology informatics and computational approaches. Notably, his 2023 publication "Computational pathology in 2030" represents a forward-looking Delphi study forecasting AI's role in pathology. His research demonstrates how informatics can enhance diagnostic accuracy, improve workflow, and support clinical decision-making across multiple pathology subspecialties. Dr. Sinard has received numerous prestigious awards recognizing his contributions to pathology: Lifetime Achievement Award (2018) from College of American Pathologists Averill Liebow Resident Teaching Award (2018) from Yale Pathology F.K. Mostofi Distinguished Service Award (2017) from United States and Canadian Academy of Pathology Averill Liebow Resident Teaching Award (2003) from Yale Pathology Averill Liebow Resident Teaching Award (1999) from Yale Pathology As Medical Director of Pathology Informatics, Dr. Sinard leads Yale Pathology Informatics, a program he helped build from the ground up. He has developed in-house software systems that "don't exist anywhere else in the world," which facilitate specimen accuracy and provide critical diagnostic information to pathologists. His approach emphasizes understanding clinical workflow alongside information systems capabilities to optimize pathologist productivity and patient safety. Dr. Sinard has been instrumental in developing the department's informatics infrastructure and has contributed to pathology practice management through publications like "Measuring Faculty Effort: A Quantitative Approach That Aligns Personal and Institutional Goals in Pathology at Yale." Dr. Sinard founded and leads the Pathology Informatics Program at Yale, which has become a model for academic pathology departments seeking to integrate advanced information systems into clinical practice. His team has developed custom software solutions that address specific challenges in pathology workflow, specimen tracking, and diagnostic support. The program emphasizes the importance of pathologists being actively involved in the design and implementation of informatics tools to ensure they meet clinical needs while enhancing patient care quality and safety.

• Pathology Informatics
• Ophthalmic Pathology
• Translational Informatics
• +۳ مورد دیگر